AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain
Open accessAbstract
Signal transduction by the antigen receptor complexes is critical for developmental progression of B-lymphocytes, which are defined by assembly and sequential expression of immunoglobulin genes, which in turn are regulated by the enhancer elements. Although proximal antigen-receptor signal transduction pathways are well defined, the precise nuclear factors targeted by these signals remained unknown. Previous studies have demonstrated that tissue-restricted transcription factors including PU.1 and PU.1 interaction partner (PIP) function synergistically with c-Fos plus c-Jun to stimulate the kappaE3'-enhancer in 3T3 cells. In this study, we demonstrate that the functional synergy between these factors is enhanced in response to mitogen-activated protein kinase kinase kinase, in 3T3 cells, where the enhancer is inactive. However in S194 plasmacytoma cells, mitogen-activated protein kinase kinase kinase was able to stimulate the activity of PU.1 but unable to induce the kappaE3'-enhancer activity. We have found that Ras-phosphoinositide 3-kinase-dependent externally regulated kinase, AKT, induces kappaE3'-enhancer activity in both pre-B and plasmacytoma cells. AKT stimulation of the kappaE3'-enhancer is primarily due to PU.1 induction and is independent of PU.1 interaction with PIP. Activation of AKT had no effect on the expression levels of PU.1 or its protein-protein interaction with PIP. Using a series of deletion constructs, we have determined that the PU.1 acid-rich (amino acids 33-74) transactivation domain is necessary for AKT-mediated induction. Substitution analyses within this region indicate that phosphorylation of Ser(41) is necessary to respond to AKT. Consistent with these studies, ligation of antigen receptors in A20 B cells mimics AKT activation of PU.1. Taken together, these results provide evidence that PU.1 is induced by AKT signal in a phosphoinositide 3-kinase-dependent manner, leading to inducible or constitutive activation of its target genes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PI3K-AKT signaling can modulate the activity of PU.1 via phosphorylating it.
“As PI3K-AKT signaling can also modulate the activity of PU.1 via phosphorylating it (Rieske and Pongubala, 2001)”
From PU.1 is required to restrain myelopoiesis during chronic inflammatory stress (2023) · cites this paper as Rieske and Pongubala, 2001
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,734 · see citing works
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,673 · see citing works
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,354 · see citing works
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 6,535 · see citing works
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 4,557 · see citing works
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · see citing works
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188 · see citing works
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E. J., Frisch, S. M., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 3,118 · see citing works
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002 · see citing works
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
del Peso, L., González‐García, M., Page, C., Herrera, R., & Núñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 2,213 · see citing works
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Özeş, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 2,175 · see citing works
Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886 · see citing works
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,847 · see citing works
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity
Hill, C. S., & Treisman, R. (1995) · Cell · doi:10.1016/0092-8674(95)90403-4 · Cited by 1,263 · see citing works
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · see citing works
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., de Ruiter, N. D., de Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 1,085 · see citing works
A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf
Lange, C. A., Pleiman, C., Gardner, A. M., Blumer, K., & Johnson, G. L. (1993) · Science · doi:10.1126/science.8385802 · Cited by 1,059 · see citing works
Chan, T. O., Rittenhouse-Simmons, S., & Tsichlis, P. N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.965 · Cited by 981 · see citing works
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · see citing works
Urbánek, P. (1994) · Cell · doi:10.1016/0092-8674(94)90079-5 · Cited by 795 · see citing works
Bain, G. (1994) · Cell · doi:10.1016/0092-8674(94)90077-9 · Cited by 779 · see citing works
Regulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749 · see citing works
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · see citing works
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L., & Tybulewicz, V. L. J. (1995) · Nature · doi:10.1038/378298a0 · Cited by 722 · see citing works
Failure of B-cell differentiation in mice lacking the transcription factor EBF
Lin, H., & Grosschedl, R. (1995) · Nature · doi:10.1038/376263a0 · Cited by 692 · see citing works
The helix-loop-helix gene E2A is required for B cell formation
Zhuang, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90076-0 · Cited by 675 · see citing works
Rapid and Preferential Activation of the c- jun Gene during the Mammalian UV Response
Devary, Y., Gottlieb, R. A., Lau, L. F., & Karin, M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.5.2804 · Cited by 667 · see citing works
Sizemore, N., Leung, S., & Stark, G. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4798 · Cited by 650 · see citing works
Madrid, L. V., Wang, C.-Y., D, D. C. G., Schottelius, A. J. G., Baldwin, A. S., & Mayo, M. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1626-1638.2000 · Cited by 634 · see citing works
Impaired B Cell Development and Proliferation in Absence of Phosphoinositide 3-Kinase p85α
Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L., Yu, J., Alt, F. W., & Cantley, L. C. (1999) · Science · doi:10.1126/science.283.5400.393 · Cited by 633 · see citing works
Syk tyrosine kinase required for mouse viability and B-cell development
Cheng, A. M., Rowley, B. R., Pao, W. J., Hayday, A., Bolen, J. B., & Pawson, T. J. (1995) · Nature · doi:10.1038/378303a0 · Cited by 629 · see citing works
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583 · see citing works
A critical role of λ5 protein in B cell development
Kitamura, D., Kudō, A., Schaal, S., Müller, W., Melchers, F., & Rajewsky, K. (1992) · Cell · doi:10.1016/0092-8674(92)90293-l · Cited by 577 · see citing works
Grosschedl, R., & Baltimore, D. (1985) · Cell · doi:10.1016/s0092-8674(85)80069-6 · Cited by 520 · see citing works
Minden, A., Lin, A., Smeal, T., Dérijard, B., Cobb, M. H., Davis, R. J., & Karin, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6683 · Cited by 467 · see citing works
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works
Zhang, D. E., Hetherington, C. J., Chen, H. M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373 · Cited by 411 · see citing works
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411 · see citing works
Targeted disruption of µ chain membrane exon causes loss of heavy-chain allelic exclusion
Kitamura, D., & Rajewsky, K. (1992) · Nature · doi:10.1038/356154a0 · Cited by 375 · see citing works
Ceramide Activates the Stress-activated Protein Kinases
Westwick, J. K., Bielawska, A. E., Dbaibo, G. S., Hannun, Y. A., & Brenner, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22689 · Cited by 369 · see citing works
Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354 · see citing works
Self-citationThe complexity of signaling pathways activated by the BCR
DeFranco, A. L. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80074-x · Cited by 318 · see citing works
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301 · see citing works
Regulation of an Early Developmental Checkpoint in the B Cell Pathway by Igβ
Gong, S., & Nussenzweig, M. C. (1996) · Science · doi:10.1126/science.272.5260.411 · Cited by 300 · see citing works
Hohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5830 · Cited by 284 · see citing works
Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR Complex
Torres, R. M., Flaswinkel, H., Reth, M. G., & Rajewsky, K. (1996) · Science · doi:10.1126/science.272.5269.1804 · Cited by 283 · see citing works
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 282 · see citing works
Self-citationXia, Y., Makris, C., Su, B., Li, E., Yang, J., Nemerow, G. R., & Karin, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5243 · Cited by 276 · see citing works
Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242 · see citing works
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 232 · see citing works
The Inositol Phosphatase SHIP Inhibits Akt/PKB Activation in B Cells
Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T., & Ravichandran, K. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33922 · Cited by 217 · see citing works
Brass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 207 · see citing works
Chen, H. M., Pahl, H. L., Scheibe, R. J., Zhang, D. E., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53086-6 · Cited by 199 · see citing works
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · see citing works
Molecular mechanisms in B cell antigen receptor signaling
Kurosaki, T. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80075-1 · Cited by 192 · see citing works
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452 · Cited by 182 · see citing works
The transcription factor PU.1 is involved in macrophage proliferation.
Celada, A., Borràs, F. E., Soler, C., Lloberas, J., Klemsz, M., van Beveren, C., McKercher, S., & Maki, R. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.61 · Cited by 161 · see citing works
Hagman, J., & Grosschedl, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8889 · Cited by 143 · see citing works
Wu, H., Moulton, K. S., Horvai, A., Parik, S., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2129 · Cited by 138 · see citing works
Sharpe, M. J., Milstein, C., Jarvis, J. M., et al. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07748.x · Cited by 132 · see citing works
Shin, M. K., & Koshland, M. E. (1993) · Genes & Development · doi:10.1101/gad.7.10.2006 · Cited by 126 · see citing works
Pongubala, J. M. R., & Atchison, M. L. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1040 · Cited by 123 · see citing works
Self-citationEichbaum, Q. G., Iyer, R., Raveh, D., Mathieu, C., & Ezekowitz, R. A. B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1985 · Cited by 119 · see citing works
Functional dissection of BCR signaling pathways
Kurosaki, T. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00087-x · Cited by 117 · see citing works
Somatic hypermutation: How many mechanisms diversify V region sequences?
Maizels, N. (1995) · Cell · doi:10.1016/0092-8674(95)90227-9 · Cited by 115 · see citing works
Ray-Gallet, D., Mao, C. D., Tavitian, A., & Moreau-Gachelin, F. (1995) · PubMed · Cited by 105 · see citing works
Roles of IFN Consensus Sequence Binding Protein and PU.1 in Regulating IL-18 Gene Expression
Kim, Y.-M., Kang, H.-S., Paik, S., Pyun, K.-H., Anderson, K. L., Torbett, B. E., & Choi, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2000 · Cited by 104 · see citing works
Positive and negative roles of the tyrosine kinase Lyn in B cell function
DeFranco, A. L., Chan, V. W.-F., & Lowell, C. A. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0122 · Cited by 94 · see citing works
CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity.
Rosmarin, A. G., Caprio, D. G., Levy, R., & Simkevich, C. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.801 · Cited by 94 · see citing works
Feinman, R., Qiu, W. Q., Pearse, R. N., Nikolajczyk, B. S., Sen, R., Sheffery, M., & Ravetch, J. V. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06696.x · Cited by 88 · see citing works
PU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86 · see citing works
Self-citationMoulton, K. S., Semple, K., Wu, H., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4408 · Cited by 86 · see citing works
Himmelmann, A. W., Riva, A., Wilson, G. L., Lucas, B. P., Thévenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 84 · see citing works
Shaw, A. C., Swat, W., Ferrini, R., Davidson, L., & Alt, F. W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.123 · Cited by 82 · see citing works
Gold, M., Ingham, R., McLeod, S. J., Christian, S., Scheid, M., Duronio, V., Santos, L., & Matsuuchi, L. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00601.x · Cited by 80 · see citing works
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77 · see citing works
Grossman, A., Mittrücker, H.-W., Nicholl, J. K., Suzuki, A., Chung, S., Antonio, L., Suggs, S., Sutherland, G. R., Siderovski, D. P., & Mak, T. W. (1996) · Genomics · doi:10.1006/geno.1996.0547 · Cited by 76 · see citing works
The Myeloid-Cell-Specific c-fesPromoter Is Regulated by Sp1, PU.1, and a Novel Transcription Factor
Heydemann, A., Juang, G., Hennessy, K., Parmacek, M. S., & Simon, M. C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1676 · Cited by 75 · see citing works
Kim, B.-C., Lee, M.-N., Kim, J., Lee, S. S., Chang, J.-D., Kim, S. S., Lee, S.-Y., & Kim, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24372 · Cited by 58 · see citing works
Hiramatsu, R., Akagi, K., Matsuoka, M., Sakumi, K., Nakamura, H., Kingsbury, L., David, C. S., Hardy, R. R., Yamamura, K., & Sakano, H. (1995) · Cell · doi:10.1016/0092-8674(95)90138-8 · Cited by 57 · see citing works
Fisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49 · see citing works
Self-citationPongubala, J. M. R., & Atchison, M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10304 · Cited by 38 · see citing works
Self-citationBuras, J. A., Reenstra, W. R., & Fenton, M. J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00018-a · Cited by 34 · see citing works
Inaba, T., Gotoda, T., Ishibashi, S., Harada, K., Ohsuga, J.-I., Ohashi, K., Yazaki, Y., & Yamada, N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2264 · Cited by 28 · see citing works
PU.1/Spi-1 Is Essential for the B Cell-Specific Activity of the Mouse CD72 Promoter
Ying, H., Chang, J.-F., & Parnes, J. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2287 · Cited by 27 · see citing works
Counterselection against Dμ Is Mediated through Immunoglobulin (Ig)α-Igβ
Gong, S., Sanchez, M., & Nussenzweig, M. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2079 · Cited by 24 · see citing works
Flagged first, then by citations
Research works printed but not linked: 11
- Pongubala, 1992, Mol. Cell. Biol., 12, 368
- Devary, 1991, Mol. Cell. Biol., 11, 2804
- Minden, 1994, Mol. Cell. Biol., 14, 6683
- Pongubala, 1991, Mol. Cell. Biol., 11, 1040
- Hall, 1983, J. Mol. Appl. Genet., 2, 101
- Gorman, 1982, Mol. Cell. Biol., 2, 1044
- Eisenbeis, 1993, Mol. Cell. Biol., 13, 6452
- Ray-Gallet, 1995, Oncogene, 11, 303
- Zhang, 1994, Mol. Cell. Biol., 14, 373
- Moulton, 1994, Mol. Cell. Biol., 14, 4408
- Wu, 1994, Mol. Cell. Biol., 14, 2129
Cited by
Sorted by citations
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 684 · see citing works
The PI‐3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3
Kane, L., & Weiss, A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00008.x · Cited by 260 · see citing works
MOLECULAR GENETICS OF T CELL DEVELOPMENT
Rothenberg, E. V., & Taghon, T. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115737 · Cited by 256 · see citing works
Hassan, M. I., Waheed, A., Yadav, S., Singh, T. P., & Ahmad, F. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8463-x · Cited by 122 · see citing works
Hedl, M., Yan, J., & Abraham, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.060 · Cited by 105 · see citing works
“…transcription factors might be regulating glycolytic gene expression; SP1 and PU.1 can be activated downstream of Akt signaling (Pore et al., 2004; Rieske and Pongubala, 2001) and we identified putative binding sites for these transcription factors in the glycolytic gene promoters based on JASPAR.”
Phuchareon, J., McCormick, F. P., Eisele, D. W., & Tetsu, O. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510733112 · Cited by 105 · see citing works
T Cell Lineage Commitment: Identity and Renunciation
Rothenberg, E. V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003703 · Cited by 90 · see citing works
Adiponectin Promotes Endotoxin Tolerance in Macrophages by Inducing IRAK-M Expression
Zacharioudaki, V., Androulidaki, A., Arranz, A., Vrentzos, G. E., Margioris, A. N., & Tsatsanis, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803694 · Cited by 69 · see citing works
Function of PEA3 Ets Transcription Factors in Mammary Gland Development and Oncogenesis
Kurpios, N. A., Sabolic, N. A., Shepherd, T. G., Fidalgo, G. M., & Hassell, J. A. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025948823955 · Cited by 63 · see citing works
Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway
Miranda, M. B., Xu, H., Torchia, J. A., & Johnson, D. E. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.03.016 · Cited by 62 · see citing works
Transcriptional Regulation of the Cyclooxygenase-2 Gene in Macrophages by PU.1
Joo, M., Park, G. Y., Wright, J. G., Blackwell, T. S., Atchison, M. L., & Christman, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306267200 · Cited by 55 · see citing works
Subversion of T lineage commitment by PU.1 in a clonal cell line system
Dionne, C. J., Tse, K. Y., Weiss, A. H., Franco, C. B., Wiest, D. L., Anderson, M. K., & Rothenberg, E. V. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.01.027 · Cited by 54 · see citing works
Nawaz, Z., Patil, V. S., Paul, Y., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0557-8 · Cited by 53 · see citing works
“1 by modifying it post-translationally through phosphorylation [35].”
Richards, J. S., Fan, H.-Y., Liu, Z., Tsoi, M. F., Lague, M.-N., Boyer, A., & Boerboom, D. (2011) · Oncogene · doi:10.1038/onc.2011.341 · Cited by 53 · see citing works
Leptin up-regulates TLR2 in human monocytes
Jaedicke, K. M., Roythorne, A., Padget, K., Todryk, S. M., Preshaw, P. M., & Taylor, J. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211606 · Cited by 50 · see citing works
Zhong, H., Takeda, A., Nazari, R., Shio, H., Blobel, G., & Yaseen, N. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412878200 · Cited by 40 · see citing works
Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis
Wang, L., Wang, E., Balcazar, J. P., Wu, Z., Xiang, K., Wang, Y., Huang, Q., Negrete, M., Chen, K., Li, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202004673 · Cited by 34 · see citing works
Functional analysis of PU.1 domains in monocyte‐specific gene regulation
Nishiyama, C., Nishiyama, M., Ito, T., Masaki, S., Masuoka, N., Yamane, H., Kitamura, T., Ogawa, H., & Okumura, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00116-4 · Cited by 34 · see citing works
Partington, G. A., Fuller, K., Chambers, T. J., & Pondel, M. D. (2003) · Bone · doi:10.1016/j.bone.2003.11.010 · Cited by 33 · see citing works
“1’s ability to trans-activate gene transcription can be modulated by its phosphorylation state [22,23].”
BackgroundWei, P. Y., Taniguchi, S., Sakai, Y., Imamura, M., Inoguchi, T., Nawata, H., Oda, S., Nakabeppu, Y., Nishimura, J., & Ikuyama, S. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi136 · Cited by 28 · see citing works
Lindner, H. B., Zhang, A., Eldridge, J. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018996 · Cited by 27 · see citing works
“1 is a downstream target of Akt1 in the B-cell lineage [36].”
BackgroundOchiai, K., Shima, H., Tamahara, T., Sugie, N., Funayama, R., Nakayama, K., Kurosaki, T., & Igarashi, K. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00077-6 · Cited by 24 · see citing works
“Considering that the transcriptional function of PU.1 is activated by AKT (Rieske and Pongubala, 2001), PU.1-IRF4 regulate the expression of Bcl6 in both naive B cells and activated B cells.”
BackgroundLapko, N., Zawadka, M., Połosak, J., Worthen, G. S., Danet-Desnoyers, G. A., Puzianowska‐Kuźnicka, M., & Laudański, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00401 · Cited by 24 · see citing works
Zawlik, I., Witusik‐Perkowska, M., Hułas-Bigoszewska, K., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.021 · Cited by 20 · see citing works
Self-citationBreig, O., Théoleyre, O., Douablin, A., & Baklouti, F. (2010) · Oncogene · doi:10.1038/onc.2010.29 · Cited by 19 · see citing works
Gaines, P. C. W., Lamoureux, J., Marisetty, A., et al. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.02.009 · Cited by 19 · see citing works
Mirnics, Z. K., Caudell, E., Gao, Y.-H., Kuwahara, K., Sakaguchi, N., Kurosaki, T., Burnside, J., Mirnics, K., & Corey, S. (2004) · Journal of Immunology · doi:10.4049/jimmunol.172.7.4133 · Cited by 22 · see citing works
Organ, S. L., Hai, J., Radulovich, N., Marshall, C. B., Leung, L., Sasazuki, T., Shirasawa, S., Zhu, C., Navab, R., Ikura, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086103 · Cited by 18 · see citing works
Carlsson, R., Persson, C., & Leanderson, T. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00032-4 · Cited by 18 · see citing works
Gross, S., Zheng, J.-H., Le, A., Kerzic, P. J., & Irons, R. (2006) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0128-7 · Cited by 17 · see citing works
“…role in B cell proliferation via the phosphorylation of Ser 41 on PU.1 protein, and inhibitory kappa kinase (IKK) has also been described as capable of PU.1 phosphorylation (Mao et al., 1996; Lodie et al., 1997; Xue et al., 1999; Rieske and Pongubala, 2001; Marden et al., 2003; Wang et al., 2003).”
Curtiss, B. M., VanCampen, J., Macaraeg, J., Kong, G., Taherinasab, A., Tsuchiya, M., Yashar, W. M., Tsang, Y. H., Horton, W. R., Coleman, D. J., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01594-1 · Cited by 16 · see citing works
“PU.1 is phosphorylated at Ser148 [42, 43] leading to increased activity and DNA binding.”
BackgroundPU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner
Houston, I. B., Huang, K. J., Jennings, S. R., & DeKoter, R. P. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.003 · Cited by 15 · see citing works
PU.1 is required to restrain myelopoiesis during chronic inflammatory stress
Chavez, J. S., Rabe, J. L., Niño, K. E., Wells, H. H., Gessner, R. L., Mills, T. S., Hernandez, G., & Pietras, E. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1204160 · Cited by 14 · see citing works
“As PI3KAKT signaling can also modulate the activity of PU.1 via phosphorylating it (Rieske and Pongubala, 2001), further studies can address the extent to which the PI3K-AKT pathway drives IL1β-dependent gene regulation by PU.1.”
BackgroundAutophagy as a pharmacological target in hematopoiesis and hematological disorders
Orsini, M., Morceau, F., Dicato, M. A., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.007 · Cited by 13 · see citing works
Azim, A. C., Wang, X., Park, G. Y., Sadikot, R. T., Cao, H., Mathew, B., Atchison, M., van Breemen, R. B., Joo, M., & Christman, J. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7868 · Cited by 13 · see citing works
Marden, C. M., Stefanidis, D., Cunninghame‐Graham, D. S., & Casimir, C. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00727-7 · Cited by 12 · see citing works
Kim, J., Ogata, Y., Ali, H., & Feldman, R. A. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2003.12.004 · Cited by 11 · see citing works
Chen, K. Y., Angulo, A. D., Guo, X., More, A., Ochsner, S. A., Lopez, E., Saul, D., Pang, W., Sun, Y., McKenna, N. J., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2021.803482 · Cited by 8 · see citing works
“For example, robust intersections of aPU.1KO-repressed gene sets with transcriptomic HCTs for members of the toll-like 32, leptin 33, and chemokine 34 receptor and Protein kinase B/Akt 35 families are consistent with previous studies implicating signaling through these nodes in PU.1 function (Fig.”
ResultEditorial: PRL-Releasing Peptide Stimulation of PRL Gene Transcription—Enter AKT
Duval, D. L., & Gutierrez‐Hartmann, A. (2002) · Endocrinology · doi:10.1210/endo.143.1.8647 · Cited by 8 · see citing works
Breig, O., Théoleyre, O., & Baklouti, F. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.011 · Cited by 7 · see citing works
Ishii, H., Sen, R., & Pazin, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308973200 · Cited by 6 · see citing works
Lindner, H. B., Zhang, A., Eldridge, J. D., et al. (2011) · PLoS ONE · doi:10.1371/annotation/3966fcd7-6127-45e0-80e6-55063875e826 · Cited by 6 · see citing works
Evidence against requirement of Ser41 and Ser45 for function of PU.1 – Molecular cloning of rat PU.1
Nishiyama, C., Masuoka, N., Nishiyama, M., Ito, T., Yamane, H., Okumura, K., & Ogawa, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.008 · Cited by 5 · see citing works
Wang, N., Su, Q., Boeckh-Herwig, S., Yaneva, M., & Tempst, P. (2004) · Leukemia Research · doi:10.1016/j.leukres.2003.12.005 · Cited by 5 · see citing works
“1 and other ETS-family factors have often been implicated in myeloid specific gene expression [13,14,34,35], and their stimulatory capacity correlated with a phosphorylated state [30,36,37].”
BackgroundJaeger, H. K., Davis, D. A., Nair, A., Shrestha, P., Stream, A., Yaparla, A., & Yarchoan, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-38156-z · Cited by 4 · see citing works
Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.
Li, Z.-Y., Cui, L., Ding, M., Weng, X., Sheng, Y., Wu, J., Lü, H., & Cai, X. (2020) · Europe PMC (PubMed Central) · Cited by 4 · see citing works
Curtiss, B. M., VanCampen, J., Kong, G., Yashar, W. M., Tsang, Y. H., Horton, W. R., Coleman, D. J., Estabrook, J., Lusardi, T. A., Mills, G. B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.24.456354 · Cited by 3 · see citing works
Ochiai, K., & Igarashi, K. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105284 · Cited by 2 · see citing works
Signal transduction pathways regulating granulocyte differentiation and function
Verploegen, S. A. B. W. (2002) · Utrecht University Repository (Utrecht University)
Molecular genetics of T cell development
Rothenberg, E. V., & Taghon, T. (2005) · Ghent University Academic Bibliography (Ghent University)
Brg1 regulates fibroblast-myofibroblast transition to promote renal fibrosisPreprint
Wu, X., Luo, Y., Kang, A., Ni, J., Kong, M., & Zhang, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.22.572996
“Alternatively, there is also evidence to suggest that Rho(56) and Akt(57) may directly stimulate PU.1 activity.”
BackgroundRamani, M., Nguyen, N., Solis, J., Tenen, D. G., & Trinh, B. Q. (2026) · Biology · doi:10.3390/biology15181657
“For example, phosphorylation of Ser148 promotes interaction with the cofactor IRF4 (NF-EM5), supporting full transcriptional activation [40], whereas AKT-mediated phosphorylation within the transactivation domain, including at Ser41, enhances PU.1 activity [57].”
- Authors
- Rieske, P., & Pongubala, J. R.
- Affiliations
- Hahnemann University Hospital (US)
- ORCID
- Rieske, Piotr
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 276
- Issue
- 11
- Pages
- 8460-8468
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2010002487
- Semantic Scholar
- 74ad672a87fcf0dc0f289f38f835080f51bb89e3
- Cited by
- 53
- References
- 87
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Akt, PU.1, transactivation domain, phosphatidylinositol 3-kinase, antigen receptor signaling, B cell development, pre-B cells, plasmacytoma cells
- MeSH terms
- Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Animals, DNA, DNA-Binding Proteins, Enhancer Elements, Genetic, Phosphorylation, Proto-Oncogene Proteins, Receptors, Antigen, B-Cell, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review